NCT04005690 2026-02-27Targeted Pathway Inhibition in Patients With Pancreatic CancerOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Recruiting90 enrolled
NCT07174570 2026-01-28Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerEmory UniversityPhase 2 Recruiting39 enrolled
NCT02576561 2017-10-25Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSILTHEVAX Genetics VaccinePhase 2 Unknown10 enrolled